Scleroderma-related interstitial lung disease: principles of management
Sign Up to like & getrecommendations! Published in 2019 at "Expert Review of Respiratory Medicine"
DOI: 10.1080/17476348.2019.1575732
Abstract: ABSTRACT Introduction: Interstitial lung disease (ILD) is the most common cause of mortality in systemic sclerosis; accounting for approximately 35% of deaths. Although immunosuppression is currently opted as first line therapy for scleroderma-related ILD (SSc-ILD),… read more here.
Keywords: ssc ild; lung disease; disease; scleroderma related ... See more keywords